Harvard in Cambridge, Massachusetts; Yale in New Haven, Connecticut; Brown University in Providence, Rhode Island; the University of Pennsylvania in Philadelphia; Oregon Health & Science University in Portland; and Boston University in Boston will release a statement today that will guide how drugs developed by scientists at the schools are licensed to companies, said Kevin Casey, a spokesman for Harvard. Representatives from the six institutions signed the statement after campus groups pushed for policies to make new treatments available at low cost to poor patients. (Ver...)
Ver... 
Many of the world's most important medicines and public health devices are wholly or partly developed in academic laboratories. Their accessibility to those living in poor nations is profoundly affected by the research, licensing and patenting decisions made by universities.
As members of these institutions of higher learning, we believe that universities have an opportunity and a responsibility to improve global access to public health goods--particularly those they have helped develop.
Ver traducción al castellano del tema tomada del Observatorio del Medicamento (Colombia)
Entradas
No hay comentarios:
Publicar un comentario